antares pharma inc (ATRS:NASDAQ CM)
Paul K. Wotton Ph.D.
|Age||Total Calculated Compensation||This person is connected to 25 board members in 2 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Paul K. Wotton, Ph.D. has been the Chief Executive Officer and President of Ocata Therapeutics, Inc. (alternative name Advanced Cell Technology Inc.) since July 2014. Dr. Wotton has over 20 years of experience in the pharmaceutical industry with both large and specialty pharma companies. He served as the Chief Executive Officer of Antares Pharma Inc. since October 2008 until June 2014 and served as its President since July 2008 until June 2014. Dr. Wotton served ...
100 Princeton SouthPhone: 609-359-3020
Ewing, New Jersey 08628
Board Members Memberships*
Chief Executive Officer, President and Director
Director and Member of Corporate Governance & Nominating Committee
University Of London
Kingston Business School
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Olav Hellebo||Chief Executive Officer and Director|
ReNeuron Group plc
|David M. Pernock||Chairman, Chief Executive Officer and President|
Fibrocell Science, Inc.
|I. Richard Garr J.D.||Co-Founder, Chief Executive Officer, President, General Counsel and Director|
|Keith Murphy||Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee|
Organovo Holdings, Inc.
|$469.9K||Compensation as of Fiscal Year 2014.|